Powered by

LUCA Biologics launches to tackle women's health—through the microbiome

Aug 06, 2019 - FierceBiotech

Longtime microbial researcher Jacques Ravel, Ph.D., is putting 15 years of vaginal microbiome work into a new company: LUCA Biologics, which will develop “live biotherapeutics” for various women's health conditions, ranging from bacterial infections like urinary tract infection and bacterial vaginosis to preterm birth and infertility.

The company's first target will be urinary tract infection (UTI), which is estimated by the World Health Organization to affect as many as half of women ...